Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
作者信息
Shaffer Brian C, Gooptu Mahasweta, DeFor Todd, Spellman Stephen R, Stefanski Heather E, Shaw Bronwen E, Auletta Jeffery J, Devine Steven M, Jimenez Antonio M, Al Malki Monzr M
机构信息
Brian C. Shaffer, MD, MS, Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Mahasweta Gooptu, MD, Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA; Todd DeFor, MS, Stephen R. Spellman, MBS, and Heather E. Stefanski, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Bronwen E. Shaw, MD, PhD, CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Jeffery J. Auletta, MD and Steven M. Devine, MD, CIBMTR (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN; Antonio M. Jimenez, MD, MSc, Sylvester Comprehensive Cancer Center, Miller School of Medicine, Miami, FL; and Monzr M. Al Malki, MD, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
出版信息
J Clin Oncol. 2025 Feb;43(4):476-478. doi: 10.1200/JCO-24-02108. Epub 2024 Nov 6.
Abstract
摘要
相似文献
1
Reply to: Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.回复：基于移植后环磷酰胺的不匹配无关供体移植时代同种异体移植获取的差异
J Clin Oncol. 2025 Feb;43(4):476-478. doi: 10.1200/JCO-24-02108. Epub 2024 Nov 6.
2
Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation.
J Clin Oncol. 2025 Feb;43(4):475-476. doi: 10.1200/JCO-24-01824. Epub 2024 Nov 6.
3
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.国家骨髓捐赠者计划-赞助的 HLA 错配无关供者骨髓移植使用移植后环磷酰胺的多中心 II 期试验。
J Clin Oncol. 2021 Jun 20;39(18):1971-1982. doi: 10.1200/JCO.20.03502. Epub 2021 Apr 27.
4
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell Transplantation.全身照射和氟达拉滨联合移植后环磷酰胺治疗不合血缘相关或无关供者造血细胞移植。
Transplant Cell Ther. 2024 Oct;30(10):1013.e1-1013.e12. doi: 10.1016/j.jtct.2024.08.005. Epub 2024 Aug 8.
5
Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.真实世界数据显示异基因造血细胞移植中种族和民族的趋势和结果：来自国际血液和骨髓移植研究中心的报告。
Transplant Cell Ther. 2023 Jun;29(6):346.e1-346.e10. doi: 10.1016/j.jtct.2023.03.007. Epub 2023 Mar 15.
6
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.异基因造血干细胞移植联合脐带血与移植后环磷酰胺治疗急性髓系白血病的非匹配无关供者。
J Hematol Oncol. 2021 May 3;14(1):76. doi: 10.1186/s13045-021-01086-2.
7
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations.单倍体相合与非血缘 HLA 不全相合造血干细胞移植：HLA 因素和供者年龄的考虑。
Transplant Cell Ther. 2024 Sep;30(9):909.e1-909.e11. doi: 10.1016/j.jtct.2024.07.005. Epub 2024 Jul 10.
8
The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors.在难以获得匹配的无关供体的患者中，使用半相合干细胞移植作为替代供体来源。
Hematology. 2024 Dec;29(1):2338300. doi: 10.1080/16078454.2024.2338300. Epub 2024 May 16.
9
Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.采用联合供体骨髓诱导主要组织相容性复合体不匹配小鼠肺同种异体移植的接受：使用12小时非清髓性预处理方案的肺移植
Transplantation. 2016 Dec;100(12):e140-e146. doi: 10.1097/TP.0000000000001480.
10
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis.骨髓增生异常综合征患者中 HLA 错配供者：EBMT 注册分析。
Biol Blood Marrow Transplant. 2019 Jan;25(1):114-120. doi: 10.1016/j.bbmt.2018.08.026. Epub 2018 Aug 30.
本文引用的文献
1
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors.移植后环磷酰胺为主的移植物抗宿主病预防方案可减轻匹配或不匹配非亲缘供者使用导致的结局差异。
J Clin Oncol. 2024 Oct;42(28):3277-3286. doi: 10.1200/JCO.24.00184. Epub 2024 Jul 17.
2
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry.美国细胞治疗活动的当前趋势与成果，包括国际血液和骨髓移植研究中心登记处对患者前瞻性报告结果的数据收集。
Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12. doi: 10.1016/j.jtct.2024.06.021. Epub 2024 Jun 27.
3
Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation.种族/民族差异对异体移植中志愿者无关供体的可及性。
Blood Adv. 2024 Jun 11;8(11):2753-2764. doi: 10.1182/bloodadvances.2023012385.
4
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia.成人急性髓系白血病患者接受异基因移植时间差异的分析。
Blood Adv. 2023 Aug 8;7(15):3824-3833. doi: 10.1182/bloodadvances.2022008572.
5
Racial disparities in access to alternative donor allografts persist in the era of "donors for all".在“人人皆可捐献”的时代，获取替代供体同种异体移植物方面的种族差异依然存在。
Blood Adv. 2022 Oct 25;6(20):5625-5629. doi: 10.1182/bloodadvances.2022007814.
6
Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant.移植后环磷酰胺作为外周血造血干细胞 HLA 不相合非亲缘供者移植的移植物抗宿主病预防。
Blood Adv. 2021 Jun 22;5(12):2650-2659. doi: 10.1182/bloodadvances.2021004192.
7
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.国家骨髓捐赠者计划-赞助的 HLA 错配无关供者骨髓移植使用移植后环磷酰胺的多中心 II 期试验。
J Clin Oncol. 2021 Jun 20;39(18):1971-1982. doi: 10.1200/JCO.20.03502. Epub 2021 Apr 27.
8
Machine Learning Approach to Predicting Stem Cell Donor Availability.机器学习方法预测干细胞供体可用性。
Biol Blood Marrow Transplant. 2018 Dec;24(12):2425-2432. doi: 10.1016/j.bbmt.2018.07.035. Epub 2018 Jul 31.
9
Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.无关供体搜索预后评分，以支持早期人类白细胞抗原（HLA）咨询和临床决策。
Bone Marrow Transplant. 2016 Nov;51(11):1476-1481. doi: 10.1038/bmt.2016.162. Epub 2016 Jun 6.
Zotero 插件